The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Pituitary Neoplasms

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Pituitary Neoplasms


Psychiatry related information on Pituitary Neoplasms


High impact information on Pituitary Neoplasms


Chemical compound and disease context of Pituitary Neoplasms


Biological context of Pituitary Neoplasms


Anatomical context of Pituitary Neoplasms


Gene context of Pituitary Neoplasms


Analytical, diagnostic and therapeutic context of Pituitary Neoplasms


  1. Response of thyrotropin-secreting pituitary adenomas to a long-acting somatostatin analogue. Comi, R.J., Gesundheit, N., Murray, L., Gorden, P., Weintraub, B.D. N. Engl. J. Med. (1987) [Pubmed]
  2. Galactorrhea: a study of 235 cases, including 48 with pituitary tumors. Kleinberg, D.L., Noel, G.L., Frantz, A.G. N. Engl. J. Med. (1977) [Pubmed]
  3. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. Weinstein, L.S., Shenker, A., Gejman, P.V., Merino, M.J., Friedman, E., Spiegel, A.M. N. Engl. J. Med. (1991) [Pubmed]
  4. Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Heaney, A.P., Horwitz, G.A., Wang, Z., Singson, R., Melmed, S. Nat. Med. (1999) [Pubmed]
  5. Two G protein oncogenes in human endocrine tumors. Lyons, J., Landis, C.A., Harsh, G., Vallar, L., Grünewald, K., Feichtinger, H., Duh, Q.Y., Clark, O.H., Kawasaki, E., Bourne, H.R. Science (1990) [Pubmed]
  6. Adolescent girls, the menstrual cycle, and bone health. Adams Hillard, P.J., Nelson, L.M. Journal of pediatric endocrinology & metabolism : JPEM. (2003) [Pubmed]
  7. Nras loss induces metastatic conversion of Rb1-deficient neuroendocrine thyroid tumor. Takahashi, C., Contreras, B., Iwanaga, T., Takegami, Y., Bakker, A., Bronson, R.T., Noda, M., Loda, M., Hunt, J.L., Ewen, M.E. Nat. Genet. (2006) [Pubmed]
  8. The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease. Estrada, J., Boronat, M., Mielgo, M., Magallón, R., Millan, I., Díez, S., Lucas, T., Barceló, B. N. Engl. J. Med. (1997) [Pubmed]
  9. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Nakayama, K., Ishida, N., Shirane, M., Inomata, A., Inoue, T., Shishido, N., Horii, I., Loh, D.Y., Nakayama, K. Cell (1996) [Pubmed]
  10. Visual improvement with SMS 201-995 in a patient with a thyrotropin-secreting pituitary adenoma. Guillausseau, P.J., Chanson, P., Timsit, J., Warnet, A., Lajeunie, E., Duet, M., Lubetski, J. N. Engl. J. Med. (1987) [Pubmed]
  11. Feminization of hepatic S metabolism in male rats with a transplanted (MtT/F4). Eneroth, P., Gustafsson, J.A., Larsson, A., Skett, P., Stenberg, A., Sonnenschein, C. Cell (1976) [Pubmed]
  12. Induction of prolactin synthesis in rat pituitary tumor cells by 5-bromodeoxyuridine. Biswas, D.K., Lyons, J., Tashjian, A.H. Cell (1977) [Pubmed]
  13. Inappropriate secretion of antidiuretic hormone after transsphenoidal surgery for pituitary tumors. Cusick, J.F., Hagen, T.C., Findling, J.W. N. Engl. J. Med. (1984) [Pubmed]
  14. Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas. Vallar, L., Spada, A., Giannattasio, G. Nature (1987) [Pubmed]
  15. Octreotide and related somatostatin analogs in the diagnosis and treatment of pituitary disease and somatostatin receptor scintigraphy. Lamberts, S.W., Hofland, L.J., de Herder, W.W., Kwekkeboom, D.J., Reubi, J.C., Krenning, E.P. Frontiers in neuroendocrinology. (1993) [Pubmed]
  16. Control of cell growth. I. Estrogen-dependent growth in vivo of a rat pituitary tumor cell line. Sorrentino, J.M., Kirkland, W.L., Sirbasku, D.A. J. Natl. Cancer Inst. (1976) [Pubmed]
  17. Chromosome banding patterns of two transplantable pituitary tumors induced in rats by 2,4,6-trimethylaniline. Kovi, J., Morris, H.P., Kovi, E. J. Natl. Cancer Inst. (1977) [Pubmed]
  18. Metabolic effect of 3,3',5'-triiodothyronine in cultured growth hormone-producing rat pituitary tumor cells. Evidence for a unique mechanism of thyroid hormone action. St Germain, D.L. J. Clin. Invest. (1985) [Pubmed]
  19. Osteoporosis in men with hyperprolactinemic hypogonadism. Greenspan, S.L., Neer, R.M., Ridgway, E.C., Klibanski, A. Ann. Intern. Med. (1986) [Pubmed]
  20. Prolactin and aging: X-irradiated and estrogen-induced rat mammary tumorigenesis. Ito, A., Naito, M., Watanabe, H., Yokoro, K. J. Natl. Cancer Inst. (1984) [Pubmed]
  21. Increased activity of type I regulatory subunit of cyclic adenosine 3',5'-monophosphate-dependent protein kinase in estrogen-induced pituitary tumors. Piroli, G., Pignataro, O., De Nicola, A.F. J. Natl. Cancer Inst. (1992) [Pubmed]
  22. Partial purification and characterization of a peptide with growth hormone-releasing activity from extrapituitary tumors in patients with acromegaly. Frohman, L.A., Szabo, M., Berelowitz, M., Stachura, M.E. J. Clin. Invest. (1980) [Pubmed]
  23. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors. Fine, S.A., Frohman, L.A. J. Clin. Invest. (1978) [Pubmed]
  24. Cerebrospinal fluid hormone concentration in the evaluation of pituitary tumors. Jordan, R.M., Kendall, J.W., Seaich, J.L., Allen, J.P., Paulsen, C.A., Kerber, C.W., Vanderlaan, W.P. Ann. Intern. Med. (1976) [Pubmed]
  25. Purification of growth hormone-specific transcription factor GHF-1 containing homeobox. Castrillo, J.L., Bodner, M., Karin, M. Science (1989) [Pubmed]
  26. Molecular pathogenesis of pituitary tumors. Farrell, W.E., Clayton, R.N. Frontiers in neuroendocrinology. (2000) [Pubmed]
  27. Effects of corticotropin-releasing hormone and dexamethasone on proopiomelanocortin messenger RNA level in human corticotroph adenoma cells in vitro. Suda, T., Tozawa, F., Yamada, M., Ushiyama, T., Tomori, N., Sumitomo, T., Nakagami, Y., Demura, H., Shizume, K. J. Clin. Invest. (1988) [Pubmed]
  28. Corticotropin-releasing hormone excites adrenocorticotropin-secreting human pituitary adenoma cells by activating a nonselective cation current. Takano, K., Yasufuku-Takano, J., Teramoto, A., Fujita, T. J. Clin. Invest. (1996) [Pubmed]
  29. A growth hormone receptor mutation impairs growth hormone autofeedback signaling in pituitary tumors. Asa, S.L., Digiovanni, R., Jiang, J., Ward, M.L., Loesch, K., Yamada, S., Sano, T., Yoshimoto, K., Frank, S.J., Ezzat, S. Cancer Res. (2007) [Pubmed]
  30. A cyproheptadine-reversible defect in ACTH control persisting after removal of the pituitary tumor in Cushing's disease. Lankford, H.V., Tucker, H.S., Blackard, W.G. N. Engl. J. Med. (1981) [Pubmed]
  31. Identification of separate mRNAs coding for the alpha and beta subunits of thyrotropin. Vamvakopoulos, N.C., Kourides, I.A. Proc. Natl. Acad. Sci. U.S.A. (1979) [Pubmed]
  32. Effects of estradiol on prolactin and growth hormone messenger RNAs in cultured normal and neoplastic (MtT/W15 and GH3) rat pituitary cells. Song, J.Y., Jin, L., Lloyd, R.V. Cancer Res. (1989) [Pubmed]
  33. Ikaros isoforms in human pituitary tumors: distinct localization, histone acetylation, and activation of the 5' fibroblast growth factor receptor-4 promoter. Ezzat, S., Yu, S., Asa, S.L. Am. J. Pathol. (2003) [Pubmed]
WikiGenes - Universities